Clinical Trials Logo

Asthma clinical trials

View clinical trials related to Asthma.

Filter by:

NCT ID: NCT00377364 Completed - Asthma Clinical Trials

Acetaminophen (Tylenol) for Mood and Memory Changes Associated With Corticosteroid Therapy

Start date: November 2006
Phase: Phase 4
Study type: Interventional

Studies in humans and animals support that stress and/or elevations in corticosteroids lead to changes in hippocampal structure and functioning. This is important as patients with major depression frequently have elevated cortisol, and millions of patients receive prescription corticosteroids (e.g. prednisone). Both depression and corticosteroid therapy are associated with memory impairment and hippocampal atrophy. Our research uses corticosteroid-treated patients to explore interventions that might protect the brain from the effects of stress or corticosteroids. We propose to give 30 corticosteroid-treated asthma patients acetaminophen or placebo. Between group differences in mood, memory and other neurocognitive measures will serve as outcome measures.

NCT ID: NCT00373061 Completed - Asthma Clinical Trials

An Observational Study of the Use and Safety of Xolair® During Pregnancy

EXPECT
Start date: October 20, 2006
Phase: N/A
Study type: Observational

The Xolair® Pregnancy Registry is an observational study established by Genentech to obtain data on pregnancy outcomes in women who are exposed to Xolair®. Women exposed to at least one dose of Xolair® within 8 weeks prior to conception or at any time during their pregnancy will be followed to completion of their pregnancies. The evaluation of infants will be conducted at birth and at 6-month intervals until the infants are 12 months old. Follow-up of the infant will be extended until the infant is 18 months old, if the woman continues Xolair® treatment while breastfeeding.

NCT ID: NCT00370591 Completed - Asthma Clinical Trials

Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.

Start date: December 2002
Phase: Phase 4
Study type: Interventional

Comparison of two asthma treatments by lung function measures.

NCT ID: NCT00370097 Completed - Asthma Clinical Trials

FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects

Start date: August 30, 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to address an Food Drug and Administration (FDA) request to provide safety data in pre-asthmatic patients, ages 6 months to <12 months, following administration of fluticasone propionate HFA.

NCT ID: NCT00369993 Completed - Asthma Clinical Trials

Spacer Comparison In Adult Asthmatics

Start date: March 2005
Phase: Phase 2
Study type: Interventional

Spacers are used by people with respiratory diseases who have problems using MDIs (metered dose inhalers). This study used fluticasone propionate/salmeterol to look at the pharmacokinetic profiles produced by different spacers in their washed and un-washed states.

NCT ID: NCT00368576 Completed - Atherosclerosis Clinical Trials

A Study To Determine The Effect Of SB-480848 On Asthma

Start date: August 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the effects of SB-480848 with placebo in subjects with asthma.

NCT ID: NCT00368342 Completed - Asthma Clinical Trials

Chronic Bronchiolitis or Resistant Asthma?

Start date: n/a
Phase: Phase 4
Study type: Interventional

Chronic Bronchiolitis or Resistant Asthma? Testing a way to diagnosis and treatment

NCT ID: NCT00367263 Completed - Asthma Clinical Trials

Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary

Start date: October 2006
Phase: N/A
Study type: Interventional

This study is designed to evaluate a traditional paper symptom diary system versus the VOCEL Mobile Diary. Subjects will be issued in a random order each system and asked their preference at the end of their participation.

NCT ID: NCT00367016 Completed - Asthma Clinical Trials

Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)

Xolair
Start date: February 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to look at measures that will help scientists understand the way Omalizumab, an FDA-approved anti-allergy medication, works.

NCT ID: NCT00366509 Completed - Asthma Clinical Trials

Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases

Start date: September 18, 2006
Phase:
Study type: Observational

This study will examine bacteria and toxins in the mouth, lung and digestive system that may be the cause of various diseases or symptoms. H. pylori is a bacterium that produces various toxins that may contribute to lung problems. This study will examine specimens collected from the mouth, teeth, lung, digestive tract and blood to measure H. pylori and its toxins and their effects on cells. People 18 years of age and older with or without gastrointestinal disease may be eligible for this study. These include people without a history of lung disease as well as patients with any of the following: lymphangioleiomyomatosis, asthma, sarcoidosis, other chronic or genetic lung disease (e.g., chronic obstructive pulmonary disease, cystic fibrosis or eosinophilic granuloma). Participants may undergo the following tests: - Blood and urine tests, chest x-ray. - Measurement of arterial blood gases: A small needle is placed in an artery in the forearm to collect arterial blood. - Lung function tests: Subjects breathe deeply and occasionally hold their breath. They may also receive a medication that expands the airways. - Fiberoptic bronchoscopy with lavage and bronchial brushing: The subject's mouth and throat are numbed with lidocaine; a sedative may be given for comfort. A thin flexible tube called a bronchoscope is advanced through the nose or mouth into the lung airways to examine the airways. Saline (salt water) is then injected through the bronchoscope into the air passage and then removed by gentle suction. Next, a small brush is passed through the bronchoscope and an area of the airway is brushed to collect some cells for examination. - Mouth rinsing or teeth brushing to collect cells. - Endoscopy: A small needle and catheter (thin plastic tube) are placed into an arm vein to administer fluids and medications through the vein. A sedative may be given. The throat is numbed with lidocaine and a thin flexible tube called an endoscope is inserted through the mouth and down the esophagus into the stomach and upper part of the small intestine to examine those areas.